IndraLab

Statements


| 2

reach
"Alternatively, OTUB1 increases the kidney cancer cell tolerance of chemotherapeutic drugs oxaliplatin and doxorubicin through RAPTOR (Seo et al., 2023)."

reach
"In addition, OTUB1 also increases the kidney cancer cell tolerance of chemotherapeutic drugs oxaliplatin and doxorubicin through RAPTOR."